Business

With the Dow dropping more than 200 points at the opening on Tuesday, CEO Moderna is questioning the current batch of vaccines and Omicron.

The US stock benchmark fell on Tuesday morning, giving up some of Monday’s rise. In the new concern that the new Omicron strain of coronavirus is more resistant to current vaccine batches.Modana
MRNA,
-7.67%

Chief Executive Officer Stephane BancelFinancial Times In an interview.Dow Jones Industrial Average
DJIA,
-1.43%

S & P 500 index fell 0.8%
SPX,
-1.37%

The Nasdaq Composite Index was down 0.6% to 4,627.
COMP,
-1.34%

It retreated 0.4% at 15,717. Yields on 10-year benchmark government bonds were 1.44%, down from 1.529% on Monday at 3:00 EST.

With the Dow dropping more than 200 points at the opening on Tuesday, CEO Moderna is questioning the current batch of vaccines and Omicron.

Source link With the Dow dropping more than 200 points at the opening on Tuesday, CEO Moderna is questioning the current batch of vaccines and Omicron.

Back to top button